Search Within

Erel Joffe

Formats
  1. Meeting Abstract (56)
  2. Journal Article (24)
  3. Research Letter (3)
  4. Review (2)
Groups
  1. Department of Medicine (85)
  2. Hematologic Malignancies, Division of (85)
  3. Sloan Kettering Institute Postdocs (85)
  4. Survivorship Research (57)
  5. Center for Hematologic Malignancies (51)
  6. Lymphoma (50)

More Groups

People
  1. Andrew Zelenetz (47)
  2. Ariela Noy (42)
  3. Maria Palomba (42)
  4. Matthew Matasar (39)
  5. Paul Hamlin (37)
  6. Anita Kumar (36)

More People

Years
  1. 2024 (6)
  2. 2023 (9)
  3. 2022 (14)
  4. 2021 (22)
  5. 2020 (18)
  6. 2019 (13)

More Years

Publications
  1. Blood (31)
  2. Hematological Oncology (10)
  3. Journal of Clinical Oncology (9)
  4. Blood Advances (6)
  5. Blood Cancer Journal (4)
  6. International Journal of Radiation Oncology, Biology, Physics (3)

More Publications

Publishers
  1. American Society of Hematology (37)
  2. Wiley Blackwell (10)
  3. American Society of Clinical Oncology (9)
  4. Elsevier Inc. (9)
  5. Nature Publishing Group (5)
  6. Taylor & Francis Group (3)

More Publishers

Results (85)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: A multicentre, single-arm, phase 2 trial
    Journal Article

    Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V. E.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: Is 4 Gy suitable for curable patients?
    Journal Article

    Imber, B. S.; Chau, K. W.; Lee, J.; Lee, J.; Casey, D. L.; Yang, J. C.; Wijentunga, N. A.; Shepherd, A.; Hajj, C.; Qi, S.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Overall survival with tafasitamab + lenalidomide (LEN) vs routinely administered therapies for ASCT-ineligible relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Outcomes from the observational RE-MIND2 study
    Meeting Abstract

    Nowakowski, G. S.; Yoon, D. H.; Mondello, P.; Joffe, E.; Peters, A.; Fleury, I.; Greil, R.; Ku, M.; Marks, R.; Kim, K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
    Journal Article

    Herishanu, Y.; Avivi, I.; Aharon, A.; Shefer, G.; Levi, S.; Bronstein, Y.; Morales, M.; Ziv, T.; Arbel, Y. S.; Scarfò, L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Clinical outcomes and the role of observation in early‐stage follicular lymphoma
    Meeting Abstract

    Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Kumar, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • An open‐label trial of oral CA‐4948 an IRAK4 inhibitor combined with ibrutinib in adult patients with relapsed or refractory hematologic malignancies
    Meeting Abstract

    Joffe, E.; Ramchandren, R.; Nowakowski, G.; Rosenthal, A.; Tun, H. W.; Lunning, M.; Mead, M. D.; Martinez, E.; von Roemeling, R.; Leslie, L.
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
    Journal Article

    Bobillo, S.; Joffe, E.; Sermer, D.; Mondello, P.; Ghione, P.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; more...
    Blood Cancer Journal (2021)

    Fulltext@MSK | Save
  • Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue
    Journal Article

    Joffe, E.; Leyfman, Y.; Drill, E.; Rajeeve, S.; Zelenetz, A. D.; Lia Palomba, M.; Moskowitz, C. H.; Portlock, C.; Noy, A.; Horwitz, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
    Review

    Lumish, M.; Falchi, L.; Imber, B. S.; Scordo, M.; von Keudell, G.; Joffe, E.
    Journal of Hematology & Oncology (2021)

    Fulltext@MSK | Save